Two-photon photodynamic therapy of C6 cells by means of 5-aminolevulinic acid induced protoporphyrin IX. 2007

Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
Laser Research Laboratory, Ludwig-Maximilians-University, Munich, Germany. tobias.beck@med.uni-muenchen.de

Photodynamic therapy (PDT) has received increased attention as a treatment modality for malignant tumors as well as non-oncologic diseases such as age-related macular degeneration (AMD). An alternative to excite the photosensitizer by the common one-photon absorption is the method of two-photon excitation (TPE). This two-photon photodynamic therapy has the potential of improving the therapeutic outcome due to a highly localized photodynamic effect. The present study investigated the two-photon excited PDT performing in vitro experiments where C6 rat glioma cells were irradiated with a pulsed and focused fs Ti:sapphire laser emitting light at 800 nm. The irradiance distribution of the laser beam was carefully analyzed before the experiment and the applied irradiance was known for each position within the irradiated cell layer. Cells were divided into four groups and one group was incubated with 5-ALA and irradiated 4-5h later. The survival of this group was tested after irradiation by means of ethidium bromide and acridine orange staining and compared to a control group, which was irradiated under the same conditions, but not incubated with 5-ALA before. Both groups showed necrotic areas depending on the applied irradiance, the value of which at the margin of the necrotic area could be deduced from its size. 5-ALA incubated cells became necrotic after irradiation with a mean irradiance above 6.1 x 10(10) W/cm(2), while non-incubated cells remained viable. Cells of both groups became necrotic when treated with an irradiance above 10.9 x 10(10) W/cm(2). The observed affected area of the cell layers was between 0.13 mm(2) and 1.10 mm(2). Since the irradiation of non-incubated cells below the mean power density of 10.9 x 10(10) W/cm(2) induced no necrosis, apparently no thermal damage was induced in the cells and necrosis of the 5-ALA incubated cells can be ascribed to the photodynamic effect induced by two-photon excitation. The successful photodynamic treatment of a large area of a monolayer cell culture induced by two-photon excitation offers new perspectives for photodynamic treatment modalities.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011524 Protoporphyrins Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D000622 Aminolevulinic Acid A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. 5-Amino Levulinic Acid,5-Aminolaevulinate,5-Aminolevulinate,Aminolevulinic Acid Hydrochloride,Delta-Aminolevulinic Acid,Levulan,5 Amino Levulinic Acid,5 Aminolaevulinate,5 Aminolevulinate,Acid Hydrochloride, Aminolevulinic,Acid, 5-Amino Levulinic,Acid, Aminolevulinic,Acid, Delta-Aminolevulinic,Delta Aminolevulinic Acid,Hydrochloride, Aminolevulinic Acid,Levulinic Acid, 5-Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017785 Photons Discrete concentrations of energy, apparently massless elementary particles, that move at the speed of light. They are the unit or quantum of electromagnetic radiation. Photons are emitted when electrons move from one energy state to another. (From Hawley's Condensed Chemical Dictionary, 11th ed)

Related Publications

Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
June 2007, Lasers in surgery and medicine,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
December 2006, Zentralblatt fur Gynakologie,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
January 2004, Urologia internationalis,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
May 2016, Scientific reports,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
February 2001, Acta pharmacologica Sinica,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
April 2005, Molecular cancer therapeutics,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
September 2016, Oncotarget,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
July 1997, The Prostate,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
October 2016, Acta neurochirurgica,
Tobias J Beck, and Marius Burkanas, and Saulius Bagdonas, and Zita Krivickiene, and Wolfgang Beyer, and Ronald Sroka, and Reinhold Baumgartner, and Ricardas Rotomskis
November 2016, Scientific reports,
Copied contents to your clipboard!